Details for New Drug Application (NDA): 018009
✉ Email this page to a colleague
The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.
Summary for 018009
Tradename: | SARENIN |
Applicant: | Procter And Gamble |
Ingredient: | saralasin acetate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018009
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.6MG BASE/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 018009
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Procter And Gamble | SARENIN | saralasin acetate | INJECTABLE;INJECTION | 018009-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription